Exact Mass: 435.1231

Exact Mass Matches: 435.1231

Found 41 metabolites which its exact mass value is equals to given mass value 435.1231, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cys Cys Asn Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O6S2 (435.1246)


   

Cys Cys Pro Asn

(2S)-2-{[(2S)-1-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C15H25N5O6S2 (435.1246)


   

Cys Asn Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O6S2 (435.1246)


   

Cys Asn Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C15H25N5O6S2 (435.1246)


   

Cys Pro Cys Asn

(2S)-2-[(2R)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C15H25N5O6S2 (435.1246)


   

Cys Pro Asn Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C15H25N5O6S2 (435.1246)


   

Asn Cys Cys Pro

(2S)-1-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O6S2 (435.1246)


   

Asn Cys Pro Cys

(2R)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C15H25N5O6S2 (435.1246)


   

Asn Pro Cys Cys

(2R)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C15H25N5O6S2 (435.1246)


   

Pro Cys Cys Asn

(2S)-3-carbamoyl-2-[(2R)-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]propanoic acid

C15H25N5O6S2 (435.1246)


   

Pro Cys Asn Cys

(2R)-2-[(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]-3-sulfanylpropanoic acid

C15H25N5O6S2 (435.1246)


   

Pro Asn Cys Cys

(2R)-2-[(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C15H25N5O6S2 (435.1246)


   

Lys-Phe4Cl-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)-3-(4-chlorophenyl)propanoic acid

C20H22ClN3O6 (435.1197)


   

Phe4Cl-Lys-OH

(S)-7-amino-2-(3-((4-chlorobenzyl)oxy)-4-nitrobenzamido)heptanoic acid

C20H22ClN3O6 (435.1197)


   
   

(DANSYLAMINOETHYL)-TRIMETHYLAMMONIUM PERCHLORATE

(DANSYLAMINOETHYL)-TRIMETHYLAMMONIUM PERCHLORATE

C17H26ClN3O6S (435.1231)


   

fmoc-(r)-3-amino-4-(4-chloro-phenyl)-butyric acid

fmoc-(r)-3-amino-4-(4-chloro-phenyl)-butyric acid

C25H22ClNO4 (435.1237)


   

Fmoc-(R)-3-Amino-4-(3-chloro-phenyl)-butyric acid

Fmoc-(R)-3-Amino-4-(3-chloro-phenyl)-butyric acid

C25H22ClNO4 (435.1237)


   

Fmoc-(R)-3-Amino-4-(2-chlorophenyl)-butyric acid

Fmoc-(R)-3-Amino-4-(2-chlorophenyl)-butyric acid

C25H22ClNO4 (435.1237)


   

Fmoc-(S)-3-amino-4-(3-chloro-phenyl)-butyric acid

Fmoc-(S)-3-amino-4-(3-chloro-phenyl)-butyric acid

C25H22ClNO4 (435.1237)


   

Fmoc-(S)-3-Amino-4-(4-chlorophenyl)-butyric acid

Fmoc-(S)-3-Amino-4-(4-chlorophenyl)-butyric acid

C25H22ClNO4 (435.1237)


   

Fmoc-(S)-3-Amino-4-(2-chloro-phenyl)-butyric acid

Fmoc-(S)-3-Amino-4-(2-chloro-phenyl)-butyric acid

C25H22ClNO4 (435.1237)


   

Difloxacin hydrochloride

Difluoxacin hydrochloride

C21H20ClF2N3O3 (435.1161)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic

   

Danicamtiv

Danicamtiv

C16H20F3N5O4S (435.1188)


C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent

   

(1n)-4-n-Butoxyphenylsulfonyl-(2r)-n-hydroxycarboxamido-(4s)-methanesulfonylamino-pyrrolidine

(1n)-4-n-Butoxyphenylsulfonyl-(2r)-n-hydroxycarboxamido-(4s)-methanesulfonylamino-pyrrolidine

C16H25N3O7S2 (435.1134)


   

N-[5-(Ethylsulfonyl)-2-methoxyphenyl]-5-[3-(2-pyridinyl)phenyl]-1,3-oxazol-2-amine

N-[5-(Ethylsulfonyl)-2-methoxyphenyl]-5-[3-(2-pyridinyl)phenyl]-1,3-oxazol-2-amine

C23H21N3O4S (435.1253)


   

phloretin 2-O-glucoside

phloretin 2-O-glucoside

C21H23O10- (435.1291)


   

2,4-Diamino-6-ethyl-5,3-(2-trifluoromethyl-4-sulphonamidophenoxy)prop-1-yloxypyrimidine

2,4-Diamino-6-ethyl-5,3-(2-trifluoromethyl-4-sulphonamidophenoxy)prop-1-yloxypyrimidine

C16H20F3N5O4S (435.1188)


   

2-[[2-[(2,5-Dimethylphenyl)sulfonylamino]-1-oxoethyl]amino]-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

2-[[2-[(2,5-Dimethylphenyl)sulfonylamino]-1-oxoethyl]amino]-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

C20H25N3O4S2 (435.1286)


   

4-O-[2-(Acetylamino)-2-Deoxy-Beta-D-Glucopyranosyl]-5-O-Phosphono-D-Ribitol

4-O-[2-(Acetylamino)-2-Deoxy-Beta-D-Glucopyranosyl]-5-O-Phosphono-D-Ribitol

C13H26NO13P (435.1142)


   

3-[[4-(4-Fluorophenyl)-1-piperazinyl]sulfonyl]benzoic acid [2-(methylamino)-2-oxoethyl] ester

3-[[4-(4-Fluorophenyl)-1-piperazinyl]sulfonyl]benzoic acid [2-(methylamino)-2-oxoethyl] ester

C20H22FN3O5S (435.1264)


   

2-[[5-(7-Methoxy-2-benzofuranyl)-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]-1-(4-methoxyphenyl)ethanone

2-[[5-(7-Methoxy-2-benzofuranyl)-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]-1-(4-methoxyphenyl)ethanone

C23H21N3O4S (435.1253)


   

4-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-1-O-phosphono-D-ribitol

4-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-1-O-phosphono-D-ribitol

C13H26NO13P (435.1142)


   

N-[(7-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-(3-pyridinylmethyl)benzenesulfonamide

N-[(7-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-(3-pyridinylmethyl)benzenesulfonamide

C23H21N3O4S (435.1253)


   

Ampreloxetine (TFA)

Ampreloxetine (TFA)

C20H19F6NO3 (435.1269)


Ampreloxetine (TD-9855) TFA is a potent and orally active norepinephrine (NE) and serotonin 5-HT inhibitor. Ampreloxetine TFA has the potential for the research of neurogenic orthostatic hypotension[1][2].

   

1-(2-{5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene}-2-phenylacetyl)pyrrolidine-2-carboxylic acid

1-(2-{5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene}-2-phenylacetyl)pyrrolidine-2-carboxylic acid

C24H21NO7 (435.1318)


   

(2s)-1-{2-[(4e,5e)-5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene]-2-phenylacetyl}pyrrolidine-2-carboxylic acid

(2s)-1-{2-[(4e,5e)-5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene]-2-phenylacetyl}pyrrolidine-2-carboxylic acid

C24H21NO7 (435.1318)


   

1-{2-[(5e)-5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene]-2-phenylacetyl}pyrrolidine-2-carboxylic acid

1-{2-[(5e)-5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene]-2-phenylacetyl}pyrrolidine-2-carboxylic acid

C24H21NO7 (435.1318)


   

8-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-1-hydroxy-3-methyl-6-azatetraphene-7,12-dione

8-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-1-hydroxy-3-methyl-6-azatetraphene-7,12-dione

C24H21NO7 (435.1318)


   

8-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-1-hydroxy-3-methyl-6-azatetraphene-7,12-dione

8-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-1-hydroxy-3-methyl-6-azatetraphene-7,12-dione

C24H21NO7 (435.1318)